Search Results 1-10 of 127210 for T
Mayo Clinic's T Cell Engineering Lab of Saad J. Kenderian, M.B., Ch.B., studies engineered virus and cell, chimeric antigen receptor (CAR)-T cell therapy.
Survival outcomes using CAR-T cell therapy continue to be impressive for patients with some blood cancers.
T-cells have a port, or receptor, that matches to an antigen. When that happens, the T-cell turns into either a chemical weapon or an alarm bell. Both are vital ...
CAR-T cell therapy is a personalized treatment giving hope to patients diagnosed with various lymphomas. Learn more from Mayo Clinic.
Mayo Clinic's CAR-T Cell Therapy Program offers a new cancer immunotherapy that involves genetically modifying T cells to activate the immune system to ...
A new type of CAR-T cell therapy is targeted to B-cell blood cancers that have returned and no longer respond to other treatments.
To make CAR-T cells, the collected T cells are genetically treated in the lab to produce special receptors called chimeric antigen receptors, or CARs. These ...
Adrian T. Ting, Ph.D., studies the molecular mechanisms that determine cellular survival or demise, with the perspective that these basic mechanisms underlie a ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift can go twice as far to advance cancer research and care!